18 results on '"Geetanjali Chander"'
Search Results
2. Substance use among patients with incident Crohn’s disease in the United States, 2010 to 2019: a Medicaid observational study
- Author
-
Po-Hung Chen, Reeha Patel, Steven D. Miller, Ryan Jasper, Geetanjali Chander, and Susan Hutfless
- Published
- 2023
3. Transitioning off methadone: A qualitative study exploring why patients discontinue methadone treatment for opioid use disorder
- Author
-
Ashish P. Thakrar, Jarratt D. Pytell, Kenneth B. Stoller, Vickie Walters, Roger D. Weiss, and Geetanjali Chander
- Published
- 2023
4. The temporal relationship of alcohol use and subsequent self-reported health status among people with HIV
- Author
-
Jarratt D. Pytell, Ximin Li, Carol Thompson, Catherine R. Lesko, Mary E. McCaul, Heidi Hutton, D. Scott Batey, Edward Cachay, Kenneth H. Mayer, Sonia Napravnik, Katerina Christopoulos, Cui Yang, Heidi M. Crane, Geetanjali Chander, and Bryan Lau
- Published
- 2023
5. Effect of two counseling interventions on self-reported alcohol consumption, alcohol biomarker phosphatidylethanol (PEth), and viral suppression among persons living with HIV (PWH) with unhealthy alcohol use in Uganda: A randomized controlled trial
- Author
-
Judith A. Hahn, Robin Fatch, Nneka I. Emenyonu, Naomi Sanyu, Anita Katusiime, Barry Levine, W. John Boscardin, Geetanjali Chander, Heidi Hutton, Carol S. Camlin, Sarah E. Woolf-King, and Winnie R. Muyindike
- Subjects
Pharmacology ,Psychiatry and Mental health ,Pharmacology (medical) ,Toxicology - Published
- 2023
6. Overlapping epidemics of alcohol and illicit drug use among HCV-infected persons who inject drugs
- Author
-
Geetanjali Chander, Gregory D. Kirk, Shruti H. Mehta, David L. Thomas, Oluwaseun Falade-Nwulia, Laura E. Starbird, Mark S. Sulkowski, Jacquie Astemborski, and Risha Irvin
- Subjects
Adult ,Male ,Drug ,medicine.medical_specialty ,Alcohol Drinking ,Hepatitis C virus ,media_common.quotation_subject ,Population ,Medicine (miscellaneous) ,HIV Infections ,Alcohol ,Toxicology ,medicine.disease_cause ,Logistic regression ,Article ,Heroin ,Cocaine-Related Disorders ,chemistry.chemical_compound ,Liver disease ,Internal medicine ,Prevalence ,Humans ,Medicine ,Medical prescription ,Epidemics ,Substance Abuse, Intravenous ,education ,media_common ,education.field_of_study ,Heroin Dependence ,business.industry ,Hepatitis C, Chronic ,Middle Aged ,medicine.disease ,Alcoholism ,Psychiatry and Mental health ,Clinical Psychology ,chemistry ,Female ,business ,medicine.drug - Abstract
Background Alcohol use in people who inject drugs (PWID) with hepatitis C virus (HCV) infection accelerates liver disease progression. This paper describes the prevalence and associated correlates of alcohol use among HCV antibody positive PWID. Methods In a large cohort of HCV antibody positive PWID (N = 1623) followed from 2005 to 2013, we characterized alcohol use using the AUDIT-C. We used multivariable logistic regression with generalized estimated equations to examine socio-demographic, clinical, and substance use correlates of alcohol use. Results At their initial visit, 41% reported no, 21% reported moderate, and 38% reported heavy alcohol use. The odds of moderate and heavy alcohol use increased with greater intensity of substance use represented by a composite summary variable which ranged from 0 to 3 substances (street-acquired prescription drugs, non-injection cocaine/heroin, and injection drugs) used. Compared to those who used no drugs, those who used 3 substances had 3.71 odds (95% CI: 3.07–4.48) of moderate alcohol use and 3.65 odds (95% CI: 3.20–4.16) of heavy alcohol use. Conclusions The prevalence of moderate/heavy alcohol use is high among HCV antibody positive PWID and occurs frequently in combination with other drug use. This may contribute to progressive liver fibrosis thus limiting the gains achieved from HCV cure. Public health interventions need to address the overlapping epidemics of HCV, alcohol use, and other substance use in this population.
- Published
- 2019
7. Associations of Drug Use, Violence, and Depressive Symptoms with Sexual Risk Behaviors Among Women with Alcohol Misuse
- Author
-
Geetanjali Chander, Anika A.H. Alvanzo, Mary E. McCaul, Anne K. Monroe, Heidi E. Hutton, Catherine R. Lesko, and Kristen Lee
- Subjects
Adult ,medicine.medical_specialty ,Health (social science) ,Substance-Related Disorders ,Cross-sectional study ,Sexual Behavior ,Intimate Partner Violence ,Poison control ,HIV Infections ,Comorbidity ,Article ,Young Adult ,03 medical and health sciences ,Risk-Taking ,0302 clinical medicine ,Syndemic ,Maternity and Midwifery ,Injury prevention ,Prevalence ,medicine ,Humans ,030212 general & internal medicine ,Young adult ,Psychiatry ,030505 public health ,Unsafe Sex ,Depression ,business.industry ,Public Health, Environmental and Occupational Health ,Obstetrics and Gynecology ,Middle Aged ,medicine.disease ,Confidence interval ,Cross-Sectional Studies ,Domestic violence ,Female ,0305 other medical science ,business - Abstract
Background Alcohol misuse is associated with increased human immunodeficiency virus sexual risk behaviors by women. Drug use, intimate partner violence (IPV), and depressive symptoms frequently co-occur, are well-recognized alcohol misuse comorbidities, and may interact to increase risk behaviors. Using a syndemic framework we examined associations between drug use, IPV, and depressive symptoms and sexual risk behaviors by 400 women with alcohol misuse attending an urban sexually transmitted infections clinic. Methods Participants completed computer-assisted interviews querying drug use, IPV, and depressive symptoms and sexual risk behavior outcomes—unprotected sex under the influence of alcohol, sex for drugs/money, and number of lifetime sexual partners. We used multivariable analysis to estimate prevalence ratios (PR) for independent and joint associations between drug use, IPV, and depressive symptoms and our outcomes. To investigate synergy between risk factors we calculated the relative excess prevalence owing to interaction for all variable combinations. Results In multivariable analysis, drug use, IPV, and depressive symptoms alone and in combination were associated with higher prevalence/count of risk behaviors compared with women with alcohol misuse alone. The greatest prevalence/count occurred when all three were present (unprotected sex under the influence of alcohol [PR, 2.6; 95% confidence interval, 1.3–4.9]), sex for money or drugs [PR, 2.6; 95% confidence interval, 1.7–4.2], and number of lifetime partners [PR, 3.2; 95% confidence interval, 1.9–5.2]). Drug use, IPV, and depressive symptoms did not interact synergistically to increase sexual risk behavior prevalence. Conclusions A higher prevalence of sexual risk behaviors by women with alcohol misuse combined with drug use, IPV, and depressive symptoms supports the need for alcohol interventions addressing these additional comorbidities.
- Published
- 2018
8. Computer delivered intervention for alcohol and sexual risk reduction among women attending an urban sexually transmitted infection clinic: A randomized controlled trial
- Author
-
Chelsea E. Canan, Heidi E. Hutton, Xiaoqiang Xu, Bryan Lau, Geetanjali Chander, Catherine R. Lesko, Mary E. McCaul, Jennifer Gaver, and Joseph Finkelstein
- Subjects
medicine.medical_specialty ,Research paper ,Computer delivered brief alcohol intervention ,Alcohol ,Alcohol use disorder ,law.invention ,chemistry.chemical_compound ,Social pathology. Social and public welfare. Criminology ,Randomized controlled trial ,law ,Intervention (counseling) ,Psychology ,Medicine ,Women ,Psychiatry ,HV1-9960 ,business.industry ,Alcohol dependence ,HIV ,medicine.disease ,Recreational drug use ,Comorbidity ,Mental health ,BF1-990 ,Unhealthy alcohol use ,Psychiatry and Mental health ,chemistry ,business ,human activities - Abstract
Highlights • Unhealthy alcohol use is prevalent among women attending STI clinics. • We tested whether CBI or CBI-IVR-TM, reduced alcohol use among women in this setting. • Neither CBI nor CBI-IVR-TM reduced alcohol use more than control. • 2/3 of women had an alcohol use disorder, 65% substance use, 28% depressive symptoms. • CBI is insufficient for alcohol reduction in this high severity, high comorbidity setting., Objective We sought to determine if a computer delivered brief alcohol intervention (CBI) with or without interactive voice response counseling and text messages (CBI-IVR-TM), reduced alcohol use and sexual risk behaviors compared to attention control. Methods We conducted a 3-arm RCT among women (n = 439) recruited from Baltimore City Sexually Transmitted Infection (STI) Clinics. Eligibility included: 1) consumption of >7 drinks per week or 2) ≥2 episodes of heavy episodic drinking or ≥2 episodes of sex under the influence of alcohol in the prior three months. Research assessments conducted at baseline, 3, 6 and 12 months included a 30-day Timeline Followback querying daily alcohol use, drug use, and sexual activity. We used the MINI International Neuropsychiatric Interview-DSM-IV to ascertain drinking severity. Primary alcohol outcomes included: drinking days, heavy drinking days, drinks per drinking day. Secondary sexual risk outcomes included number of sexual partners, days of condomless sex, and days of condomless sex under the influence of drugs and alcohol. Results Median age was 31 (IQR 25–44 years), 88% were African American, 65% reported current recreational drug use, and 26% endorsed depressive symptoms. On the MINI 66% met criteria for alcohol use disorder (49% alcohol dependence, 18% abuse). At follow-up, all three groups reduced drinking days, heavy drinking days, drinks per drinking day and drinks per week with no significant differences between study arms. There was no difference in sexual risk outcomes among the groups. Conclusions Among women attending an urban STI clinic single session CBI with or without IVR and text message boosters was insufficient to reduce unhealthy alcohol use or sexual risk behaviors beyond control. The high severity of alcohol use and the prevalence of mental health symptoms and other substance use comorbidity underscores the importance of developing programs that address not only alcohol use but other determinants of STI risk among women.
- Published
- 2021
9. Marijuana use and HIV treatment outcomes among PWH receiving care at an urban HIV clinic
- Author
-
Geetanjali Chander, Anika A.H. Alvanzo, Heidi E. Hutton, Catherine R. Lesko, Jeanne C. Keruly, Bryan Lau, Richard D. Moore, Sagarika Sinha, Mary E. McCaul, and Anne K. Monroe
- Subjects
Male ,0301 basic medicine ,Drug ,medicine.medical_specialty ,Urban Population ,media_common.quotation_subject ,Human immunodeficiency virus (HIV) ,Medicine (miscellaneous) ,Medication adherence ,HIV Infections ,medicine.disease_cause ,Article ,Medication Adherence ,03 medical and health sciences ,0302 clinical medicine ,Marijuana use ,Internal medicine ,mental disorders ,Humans ,Medicine ,Prospective Studies ,030212 general & internal medicine ,Viral suppression ,Hiv treatment ,Prospective cohort study ,Psychiatry ,media_common ,business.industry ,virus diseases ,Middle Aged ,Viral Load ,030112 virology ,Psychiatry and Mental health ,Clinical Psychology ,Treatment Outcome ,Anti-Retroviral Agents ,Female ,Marijuana Use ,Pshychiatric Mental Health ,business ,Viral load - Abstract
While marijuana use is prevalent among persons with HIV (PWH), few studies have examined the relationship between marijuana use and HIV treatment outcomes independent of alcohol and other drug use.We conducted a prospective cohort study to examine the relationships between frequency of marijuana use and antiretroviral therapy (ART) adherence and viral suppression in patients enrolled in the Johns Hopkins HIV Clinical Cohort between September 2013 through November 2015 (N=1377). We categorized marijuana use as no use, none in the last 3months, monthly use or less, weekly/daily. Our outcomes of interest were use of ART, ≥90 ART adherence, and viral suppression (HIV1-RNA200 copies). We conducted multivariable analyses to examine associations between the frequency of marijuana use and our treatment outcomes, using generalized estimating equations to account for repeated measures. Other independent variables of interest included alcohol use, other drug use, and depressive symptoms. Analyses were adjusted for age, race, sex and HIV acquisition risk factor.In multivariable analyses we found no statistically significant association between frequency of marijuana use and our treatment outcomes. Alcohol use, other drug use and depressive symptoms were associated with lower odds of ART adherence and viral suppression.In this sample of PWH in care, frequency of marijuana use independent of other substance use does not appear to be associated with negative HIV treatment outcomes. Our results indicate that unlike alcohol, other substances and depression, marijuana use may not be a barrier to the effective treatment of HIV.
- Published
- 2017
10. Perceptions of network based recruitment for hepatitis C testing and treatment among persons who inject drugs: a qualitative exploration
- Author
-
Kathleen M. Ward, Carl A. Latkin, Oluwaseun Falade-Nwulia, Mark S. Sulkowski, Sean D. McCormick, and Geetanjali Chander
- Subjects
Male ,medicine.medical_specialty ,media_common.quotation_subject ,Psychological intervention ,030508 substance abuse ,Medicine (miscellaneous) ,Article ,Drug Users ,03 medical and health sciences ,Social support ,0302 clinical medicine ,Health care ,medicine ,Humans ,030212 general & internal medicine ,Substance Abuse, Intravenous ,media_common ,Social network ,business.industry ,Health Policy ,virus diseases ,Hepatitis C ,medicine.disease ,Pharmaceutical Preparations ,Feeling ,Family medicine ,Baltimore ,Female ,Perception ,Personal experience ,Thematic analysis ,0305 other medical science ,business - Abstract
Background Social network interventions that take advantage of existing individual and group relationships may help overcome the significant patient, provider, and system level barriers that contribute to low hepatitis C Virus (HCV) treatment uptake among people who inject drugs (PWID). Methods We conducted semi-structured interviews with 20 HCV antibody positive PWID (15 male, 5 female) in Baltimore, Maryland, USA. We utilized thematic analysis and employed both inductive and deductive coding techniques to assess perceptions of barriers and facilitators of social network interventions for HCV testing, linkage to care, and treatment among PWID. Results PWID perceived a high prevalence of HCV within their social networks, especially within injection drug use networks. Overwhelmingly, participants reported a willingness to discuss HCV and provide informational, instrumental, and emotional support to their network members. Support included sharing knowledge, such as where and how to access HCV care, as well as sharing lived experiences about HCV treatment that could help peers build trust within networks. Participants who were already linked into HCV care had an increased understanding of using social network interventions to provide peer navigation, by accompanying network members to HCV related appointments. Across interviews, drug use related stigma and feeling undeserving of HCV treatment due to previous negative experiences accessing the health care system emerged as a major barrier to linkage to HCV treatment and cure. Undeservingness was often internalized and projected onto network members. To overcome this, participants supported access to low-barrier HCV treatment in alternative locations such as community-based or mobile clinics and drug treatment centers. Conclusion Social network based interventions have potential to increase HCV treatment uptake among PWID. To be successful, these interventions will need to train peers to share accurate information and personal experiences with HCV testing and treatment and enhance their ability to provide support to network members who face significant stigma related to both HCV and drug use.
- Published
- 2021
11. Social support modifies the association between hazardous drinking and depression symptoms among ART clients in Vietnam
- Author
-
Ha V. Tran, Heidi E. Hutton, Minh Nguyen, Quynh Bui, Carl A. Latkin, Geetanjali Chander, Vivian F. Go, Kathryn E. Lancaster, Constantine Frangakis, Teerada Sripaipan, and David W. Dowdy
- Subjects
Adult ,Male ,Social stigma ,Social Stigma ,Population ,Psychological intervention ,HIV Infections ,Toxicology ,Article ,law.invention ,03 medical and health sciences ,Social support ,0302 clinical medicine ,Randomized controlled trial ,law ,Environmental health ,Prevalence ,Humans ,Medicine ,Pharmacology (medical) ,030212 general & internal medicine ,education ,Depression (differential diagnoses) ,Pharmacology ,education.field_of_study ,Alcohol Use Disorders Identification Test ,Ethanol ,Depression ,business.industry ,Social Support ,Middle Aged ,Mental health ,Alcoholism ,Psychiatry and Mental health ,Anti-Retroviral Agents ,Vietnam ,Female ,business ,030217 neurology & neurosurgery - Abstract
Introduction Hazardous drinking is widespread among people with HIV (PWH). PWH are also vulnerable to depression due to HIV-related social stigma, and social support can play an important role in improving mental health for this population. No studies have explored whether social support modifies the association of hazardous drinking and depressive symptoms among PWH. Methods We used baseline data from a randomized controlled trial of two evidence-based alcohol reduction interventions among antiretroviral therapy clients in Vietnam. Hazardous alcohol use was defined as having a score ≥8 for men and ≥ 7 for women on the Alcohol Use Disorders Identification Test. The presence of depression symptoms was defined as a score ≥ 5 on the Patient Health Questionnaire-9. Social support was measured with a 5-question modified version of the Medical Outcomes Study Social Support Instrument. Crude (CPRs) and adjusted prevalence ratios (aPRs) of the association were presented. Results Hazardous drinking was significantly associated with increased likelihood of having depressive symptoms (aPR = 1.26;95%CI 1.04−1.52). Hazardous drinking and depression symptoms were not associated among those with high social support (aPR = 1.01;95%CI 0.76–1.35), but were associated among those with medium (aPR = 1.24;95%CI 0.92–1.69) and low social support (aPR = 1.71;95%CI 1.25–2.34). Conclusions Social support significantly modified the association between hazardous drinking and depression symptoms among ART clients in Vietnam. Interventions to decrease hazardous alcohol use are broadly indicated for PWH in Vietnam and other low-resource settings, but special attention or modifications may be needed to support mental health among those with lower levels of social support.
- Published
- 2020
12. Suitability of the PROMIS alcohol use short form for screening in a HIV clinical care setting
- Author
-
William B. Lober, Paul K. Crane, Heidi E. Hutton, Donald L. Patrick, W. Chris Mathews, Geetanjali Chander, Greer A. Burkholder, Rob J. Fredericksen, Laura E. Gibbons, Michael S. Saag, Heidi M. Crane, Mary E. McCaul, Joseph O. Merrill, Michael J. Mugavero, James H. Willig, Mari M. Kitahata, Kenneth H. Mayer, and Todd C. Edwards
- Subjects
Adult ,Male ,medicine.medical_specialty ,Alcohol Drinking ,Psychometrics ,Human immunodeficiency virus (HIV) ,Psychological intervention ,HIV Infections ,Alcohol ,Toxicology ,medicine.disease_cause ,Ambulatory Care Facilities ,Article ,03 medical and health sciences ,chemistry.chemical_compound ,Risk-Taking ,0302 clinical medicine ,Surveys and Questionnaires ,Item response theory ,medicine ,Humans ,Mass Screening ,Pharmacology (medical) ,030212 general & internal medicine ,Clinical care ,Psychiatry ,Mass screening ,Pharmacology ,Alcohol Use Disorders Identification Test ,business.industry ,Reproducibility of Results ,Middle Aged ,Alcoholism ,Psychiatry and Mental health ,chemistry ,Female ,business ,030217 neurology & neurosurgery - Abstract
Background At-risk alcohol use is important to identify in clinical settings to facilitate interventions. The Patient-Reported Outcomes Measurement Information System (PROMIS) Alcohol Use Short Form was developed through an item response theory process, but its utility as a screening instrument in clinical care has not been reported. Objective To determine the ability of the PROMIS Alcohol Use Short Form to identify people with current or future at-risk alcohol use defined by the Alcohol Use Disorders Identification Test consumption (AUDIT-C) instrument. Methods Observational study of people living with HIV (PLWH) in clinical care at four sites across the US. Patients completed a tablet-based clinical assessment prior to seeing their providers at clinic appointments. We used 3 definitions of clinically-relevant at-risk alcohol use and determined the proportion of PLWH with current or future at-risk drinking identified by the PROMIS instrument. Results Of 2497 PLWH who endorsed ≥1 drink in the prior 12 months, 1500 PLWH (60%) endorsed “never” for all PROMIS items. In that group, 26% had clinically-relevant at-risk alcohol use defined by one or more AUDIT-C definitions. At follow-up (N = 1608), high baseline PROMIS scores had 55% sensitivity for at-risk drinking among those with at-risk drinking at baseline, and 22% sensitivity among those without baseline risk. Conclusions The PROMIS Alcohol Use Short Form cannot be used alone to identify PLWH with clinically-relevant at-risk alcohol use. Optimal assessment of problem drinking behavior is not clear, but there does not seem to be an important role for the PROMIS instrument in this clinical setting.
- Published
- 2016
13. Correlates of alcohol use disorder pharmacotherapy receipt in medically insured patients
- Author
-
Anika L Hines, Alexander Rittenberg, Geetanjali Chander, and Anika A.H. Alvanzo
- Subjects
Adult ,Male ,medicine.medical_specialty ,Adolescent ,Substance-Related Disorders ,Population ,Alcohol abuse ,Comorbidity ,Alcohol use disorder ,Disease ,Toxicology ,Article ,03 medical and health sciences ,0302 clinical medicine ,Pharmacotherapy ,Internal medicine ,Outpatients ,Prevalence ,medicine ,Humans ,Pharmacology (medical) ,030212 general & internal medicine ,Medical prescription ,education ,Pharmacology ,Depressive Disorder, Major ,education.field_of_study ,business.industry ,Alcohol dependence ,Middle Aged ,medicine.disease ,Anxiety Disorders ,Alcoholism ,Psychiatry and Mental health ,Anxiety ,Female ,medicine.symptom ,business ,030217 neurology & neurosurgery - Abstract
Background Alcohol use disorder is a highly prevalent disease with multiple medications available for treatment. The overall prevalence of patients receiving pharmacotherapy is believed to be low and the characteristics and comorbidities that affect receipt are not well-established. Methods We created a dataset from Truven Health Analytics MarketScan Commercial Claims and Encounters Database of patients with an outpatient encounter for alcohol abuse or dependence in 2014. We subsequently identified patient characteristics, comorbid medical, psychiatric, or substance use disorders, as well as encounter provider specialties and, using multivariable logistic regression, assessed which variables correlated with increased or decreased receipt of pharmacotherapy for alcohol use disorder for this population. Results In our dataset of 123,355 patients, patient receipt of pharmacotherapy for alcohol use disorder was 3.3 %, and 9.3 % when restricted to the former diagnosis of alcohol dependence only. Male sex, younger age, alcohol-related liver disease, and cannabis use disorders correlated with decreased receipt whereas comorbid major depressive disorders and anxiety disorders correlated with increased receipt. Compared to patients seen by psychiatrists, those seen by primary medical doctors had a lower odds of receiving pharmacotherapy. Conclusions Pharmacotherapy for alcohol use disorder is an underutilized treatment modality with a low prevalence of prescription in insured individuals. Patients with specific characteristics and comorbidities are less likely to receive this treatment and greater focus on these patients and in the primary care setting can allow for increased prescribing of these medications.
- Published
- 2020
14. Longitudinal analysis of alcohol use and intimate partner violence perpetration among men with HIV in northern Vietnam
- Author
-
Heidi E. Hutton, Geetanjali Chander, Nguyen Vu Tuyet Mai, Tran Viet Ha, H Luz McNaughton Reyes, Carl A. Latkin, David W. Dowdy, Vivian F. Go, Constantine Frangakis, Teerada Sripaipan, Suzanne Maman, Rebecca B. Hershow, and Audrey Pettifor
- Subjects
Pharmacology ,business.industry ,education ,Poison control ,Context (language use) ,social sciences ,Odds ratio ,Alcohol use disorder ,Toxicology ,medicine.disease ,Article ,03 medical and health sciences ,Psychiatry and Mental health ,0302 clinical medicine ,Acquired immunodeficiency syndrome (AIDS) ,mental disorders ,Injury prevention ,Medicine ,Pharmacology (medical) ,030212 general & internal medicine ,Risk factor ,business ,030217 neurology & neurosurgery ,Demography ,Mini-international neuropsychiatric interview - Abstract
BACKGROUND: Alcohol use is a known risk factor for male-perpetrated intimate partner violence (IPV), although few studies have been conducted globally and among men with HIV (MWH). We estimated the longitudinal effects of alcohol use on IPV perpetration among MWH. METHODS: This study is a secondary analysis of randomized controlled trial data among male and female antiretroviral treatment patients with hazardous alcohol use in Thai Nguyen, Vietnam. Analyses were restricted to male participants who were married/cohabitating (N=313). Alcohol use was assessed as proportion days alcohol abstinent, heavy drinking, and alcohol use disorder (AUD) using the Timeline Followback and Mini International Neuropsychiatric Interview questionnaire. Multilevel modeling was used to estimate the effects of higher versus lower average alcohol use on IPV perpetration (between-person effects) and the effects of time-specific deviations in alcohol use on IPV perpetration (within-person effects). RESULTS: Participants with higher average proportion days alcohol abstinent had decreased odds of IPV perpetration (adjusted Odds Ratio [aOR]=0.43, p=0.03) and those with higher average heavy drinking and AUD had increased odds of IPV perpetration (Heavy drinking: aOR=1.05, p=0.002; AUD: aOR=4.74, p
- Published
- 2020
15. Alcohol Use and Unintended Sexual Consequences among Women Attending an Urban Sexually Transmitted Infections Clinic
- Author
-
Mary E. McCaul, Tracy Agee, Dinah Lewis, Geetanjali Chander, and Heidi E. Hutton
- Subjects
education.field_of_study ,medicine.medical_specialty ,Health (social science) ,business.industry ,Population ,Public Health, Environmental and Occupational Health ,Obstetrics and Gynecology ,Binge drinking ,Poison control ,Suicide prevention ,Occupational safety and health ,Unsafe Sex ,Maternity and Midwifery ,Injury prevention ,Medicine ,education ,business ,Psychiatry ,Social psychology ,Sex characteristics - Abstract
Background Although alcohol use has been linked with a variety of sexual behaviors, we lack an understanding of what precise events occur when women drink that may lead to emotional or physical harms. Methods To fill this gap, we qualitatively explored the unintended sexual events occurring while drinking among a particularly at-risk clinic population: urban women attending a public sexually transmitted infections (STI) clinic. This was a secondary data analysis of 20 semistructured, in-depth interviews conducted between December 2009 and August 2010 with 20 sexually active adult women attending the Baltimore City Health Department STI Clinic. We purposively sampled women presenting for care in the STI clinic who reported either binge drinking in the past 6 months or engaging in vaginal or anal intercourse while under the influence of alcohol. Interviews were analyzed using a grounded theory approach. Results Five major unintended sexual events emerged: sex with new partners; alternative sexual activities, including anal sex and “rough” sex; unprotected sex; blacked out sex or sex occurring during alcohol-related amnesia; and rape. Themes often overlapped, and sexual victimization was a common thread throughout multiple themes. An additional theme, alcohol and prey, largely occurring in bars and nightclubs, emerged as an important precursor to many of the unintended events described. Conclusions Alcohol use was associated with a variety of—often dangerous—unintended sexual events. Our results highlight the link between alcohol use and sexual victimization and the need for intervention development to reduce the emotional and physical harms resulting from the unintended consequences of alcohol use.
- Published
- 2015
16. Clinical and Mental Health Correlates and Risk Factors for Intimate Partner Violence among HIV-Positive Women in an Inner-City HIV Clinic
- Author
-
Monique Tello, Heidi E. Hutton, Richard D. Moore, Jillian Baron, Geetanjali Chander, Jean Anderson, and Samantha Illangasekare
- Subjects
Adult ,Male ,Domestic Violence ,medicine.medical_specialty ,Health (social science) ,Urban Population ,education ,Poison control ,HIV Infections ,Suicide prevention ,Article ,Occupational safety and health ,Interviews as Topic ,Young Adult ,Risk Factors ,Surveys and Questionnaires ,mental disorders ,Maternity and Midwifery ,Injury prevention ,Prevalence ,medicine ,Humans ,Medical prescription ,Psychiatry ,Depression ,business.industry ,Public Health, Environmental and Occupational Health ,Obstetrics and Gynecology ,social sciences ,Odds ratio ,Middle Aged ,Mental health ,CD4 Lymphocyte Count ,Cross-Sectional Studies ,Logistic Models ,Mental Health ,Sexual Partners ,Anti-Retroviral Agents ,Socioeconomic Factors ,Baltimore ,Multivariate Analysis ,HIV-1 ,Domestic violence ,Female ,business ,Attitude to Health - Abstract
Background Intimate partner violence (IPV) is a serious health concern for women in the United States, and HIV-positive women experience more frequent and severe abuse compared with HIV-negative women. The goals of this study were to determine the prevalence of IPV among HIV-infected women receiving care in an urban clinic and to determine the HIV clinical and mental health correlates of IPV among HIV-positive women. Methods We conducted a cross-sectional survey among 196 women visiting an inner-city HIV clinic. Women were eligible if they were 18 years of age or older, English speaking, and received both HIV primary and gynecologic care at the clinic. The survey queried demographics, drug and alcohol history, depressive symptoms, and IPV, using the Partner Violence Scale. Antiretroviral therapy (ART), CD4 cell count, HIV-1 RNA level, and appointment adherence were abstracted from clinical records. Findings Overall, 26.5% of women reported experiencing IPV in the past year. There were no differences in sociodemographics, substance use, ART prescription, CD4 count, or HIV-1 RNA level between women who experienced IPV and those who had not. Women with mild and severe depressive symptoms were significantly more likely to report IPV compared with those without, with adjusted odds ratios of 3.4 and 5.5, respectively. Women who missed gynecologic appointments were 1.9 times more likely to report experiencing IPV. Conclusions IPV is prevalent among women presenting for HIV care, and depressive symptoms or missed gynecologic appointments should prompt further screening for IPV.
- Published
- 2012
17. Substance abuse treatment in human immunodeficiency virus: The role of patient–provider discussions
- Author
-
James Hellinger, Geetanjali Chander, John A. Fleishman, Elizabeth B. Morse, Kelly A. Gebo, Seth Himelhoch, Joshua S. Josephs, and Philip T. Korthuis
- Subjects
Adult ,Male ,Drug ,medicine.medical_specialty ,Substance-Related Disorders ,media_common.quotation_subject ,Ethnic group ,Medicine (miscellaneous) ,Binge drinking ,HIV Infections ,Article ,White People ,Risk-Taking ,Acquired immunodeficiency syndrome (AIDS) ,Humans ,Medicine ,Psychiatry ,Aged ,media_common ,Physician-Patient Relations ,Primary Health Care ,business.industry ,Data Collection ,Public health ,Social environment ,Middle Aged ,medicine.disease ,Mental health ,Black or African American ,Substance abuse ,Psychiatry and Mental health ,Clinical Psychology ,Logistic Models ,Treatment Outcome ,Female ,Pshychiatric Mental Health ,business ,Risk Reduction Behavior - Abstract
Substance abuse treatment is associated with decreases in human immunodeficiency virus (HIV) risk behavior and can improve HIV outcomes. The purpose of this study was to examine factors associated with substance abuse treatment utilization, including patient-provider discussions of substance use issues. We surveyed 951 HIV-infected adults receiving care at 14 HIV Research Network primary care sites regarding drug and alcohol use, substance abuse treatment, and provider discussions of substance use issues. Although 71% reported substance use, only 24% reported receiving substance abuse treatment and less than half reported discussing substance use issues with their HIV providers. In adjusted logistic regression models, receipt of substance abuse treatment was associated with patient-provider discussions. Patient-provider discussions of substance use issues were associated with current drug use, hazardous or binge drinking, and Black race or ethnicity, though substance use was comparable between Blacks and Whites. These data suggest potential opportunities for improving engagement in substance abuse treatment services.
- Published
- 2008
18. Access to HAART and utilization of inpatient medical hospital services among HIV-infected patients with co-occurring serious mental illness and injection drug use
- Author
-
Seth Himelhoch, Paul Gaist, James Hellinger, Geetanjali Chander, Kelly A. Gebo, and John A. Fleishman
- Subjects
Adult ,Male ,medicine.medical_specialty ,Cross-sectional study ,education ,HIV Infections ,Rate ratio ,Health Services Accessibility ,Article ,Acquired immunodeficiency syndrome (AIDS) ,immune system diseases ,Antiretroviral Therapy, Highly Active ,mental disorders ,medicine ,Humans ,Substance Abuse, Intravenous ,Psychiatry ,Inpatient care ,business.industry ,Mental Disorders ,Medical record ,virus diseases ,Odds ratio ,Health Services ,medicine.disease ,Comorbidity ,Hospitalization ,Substance abuse ,Psychiatry and Mental health ,Emergency medicine ,Female ,business - Abstract
Objective Among HIV-infected individuals, we examined whether having co-occurring serious mental illness (SMI) and injection drug use (IDU) impacts: (a) receipt of highly active antiretroviral therapy (HAART), and (b) utilization of inpatient HIV services, compared to those who have SMI only, IDU only or neither SMI nor IDU. Method Demographic, clinical and resource utilization data were collected from medical records of 5119 patients in HIV primary care at four US HIV care sites in different geographic regions with on-site mental health services in 2001. We analyzed receipt of HAART using multivariate logistic regression and the number of medical hospital admissions using multivariate logistic and Poisson regression analyses, which controlled for demographic factors, receipt of HAART, CD4 count and HIV-1 RNA. Results Those with co-occurring SMI and IDU [adjusted odds ratio (AOR)=0.52; 95% confidence interval (95% CI)=0.41–0.81] and those with IDU alone (AOR=0.64; 95% CI=0.58–0.85) were significantly less likely to receive HAART than those with neither SMI nor IDU, controlling for demographic and clinical factors. Those with co-occurring SMI and IDU were more likely to use any inpatient medical services (AOR=2.22; 95% CI=1.64–3.01) and were significantly more likely to use them more frequently (incidence rate ratio=1.33; 95% CI=1.13–1.55) than those with neither SMI nor IDU, SMI only or IDU only. Conclusion HIV-infected individuals with co-occurring SMI and IDU are significantly more likely to utilize HIV-related medical inpatient services than individuals with no comorbidity or with only one comorbidity. Individuals with both SMI and IDU did not differ from those with IDU only in receipt of HAART. Inpatient hospitalizations are expensive, and efforts should be targeted towards these populations to reduce potentially avoidable inpatient care.
- Published
- 2007
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.